Steatohepatitis Stocks List

Steatohepatitis Stocks Recent News

Date Stock Title
May 8 TERN Terns Pharmaceuticals Announces Leadership Changes
May 8 BLTE Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
May 8 IONS Ionis Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 8 PLRX Pliant Therapeutics First Quarter 2024 Earnings: US$0.78 loss per share (vs US$0.67 loss in 1Q 2023)
May 8 IONS Q1 2024 Ionis Pharmaceuticals Inc Earnings Call
May 8 IONS Ionis Pharmaceuticals Inc (IONS) Q1 2024 Earnings Call Transcript Highlights: Key Developments ...
May 7 IONS Ionis Pharmaceuticals, Inc. (IONS) Q1 2024 Earnings Call Transcript
May 7 TERN Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
May 7 IONS Ionis Pharmaceuticals (IONS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
May 7 IONS Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Misses Revenue Estimates
May 7 PLRX Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™
May 7 IONS Ionis Pharmaceuticals GAAP EPS of -$0.98 beats by $0.09, revenue of $119M misses by $17.41M
May 7 IONS Ionis reports first quarter 2024 financial results
May 6 PLRX Pliant Therapeutics GAAP EPS of -$0.78 misses by $0.01
May 6 PLRX Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 6 IONS Ionis Pharmaceuticals Q1 2024 Earnings Preview
May 6 IONS Wall Street's Insights Into Key Metrics Ahead of Ionis Pharmaceuticals (IONS) Q1 Earnings
May 6 VKTX Viking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 72% of the company
May 6 BLTE Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant
May 6 BLTE Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting
Steatohepatitis

Steatohepatitis is a type of fatty liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver. Mere deposition of fat in the liver is termed steatosis, and together these constitute fatty liver changes.There are two main types of fatty liver disease: alcohol-related fatty liver disease and non-alcoholic fatty liver disease (NAFLD). Risk factors for NAFLD include diabetes, obesity and metabolic syndrome. When inflammation is present it is referred to as alcoholic steatohepatitis and nonalcoholic steatohepatitis (NASH). Steatohepatitis of either cause may progress to cirrhosis, and NASH is now believed to be a frequent cause of unexplained cirrhosis (at least in Western societies). NASH is also associated with lysosomal acid lipase deficiency.The word is from steato-, meaning "fat" and hepatitis, meaning "inflammation of the liver".

Browse All Tags